Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | MMP12 | P39900 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28218969 | 0.81 | CA12 (0.65) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL1722105 | 0.81 | CA12 (0.65) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL7055323 | 0.81 | ALDH1A1 (0.68) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL11231967 | 0.80 | IDO1 (0.50) | ALDH1A1CA12CA1CA2CA9 | |
| Hydrochloric Acid SCHEMBL11753023 | 0.79 | CA12 (0.63) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL11686215 | 0.78 | HCAR2 (0.49) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL7049526 | 0.77 | ALDH1A1 (0.63) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL13189381 | 0.77 | ALDH1A1 (0.63) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL10767903 | 0.77 | CA12 (0.61) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL960 | 0.77 | ALDH1A1 (1.00) | ALDH1A1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11845726-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2023-12-19 | — | — | US | claimed |
| CN-107532229-B | Process for leaching metal sulphides with an agent having a thiocarbonyl function | 不列颠哥伦比亚大学 | 2021-10-08 | — | — | CN | claimed |
| JP-59122459-A | — | — | None | — | — | JP | disclosed |
| JP-59144752-A | — | — | None | — | — | JP | disclosed |
| US-20250352513-A2 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | ENVERIC BIOSCIENCES CANADA INC (CA) | 2025-11-20 | — | — | US | disclosed |
| US-20250205197-A1 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2025-06-26 | — | — | US | disclosed |
| US-20250206701-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2025-06-26 | — | — | US | disclosed |
| EP-4493542-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2025-01-22 | — | — | EP | disclosed |
| EP-4493544-A1 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2025-01-22 | — | — | EP | disclosed |
| US-11945778-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2024-04-02 | — | — | US | disclosed |
| US-11845726-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | Enveric Biosciences Canada Inc. (CA) | 2023-12-19 | — | — | US | disclosed |
| US-20150359786-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | TRANA DISCOVERY, INC. | 2015-12-17 | — | — | US | disclosed |
| US-5962487-A | PICORNAVIRAL 3C PROTEASE INHIBITORS | AGOURON PHARMACEUTICALS, INC. (US) | 1999-10-05 | — | — | US | disclosed |
| US-5171356-A | Thiolcarbamate and nonphytotoxic extender which minimizes soil degradation | ICI AMERICAS INC. (US) | 1992-12-15 | — | — | US | disclosed |
| EP-0175332-B1 | HERBICIDE COMPOSITIONS OF EXTENDED SOIL LIFE | STAUFFER CHEMICAL COMPANY (US) | 1992-03-18 | — | — | EP | disclosed |
| US-4740623-A | BENZYL CHLORIDE REACTED WITH SODIUM HYDROSULFIDE | STAUFFER CHEMICAL COMPANY (US) | 1988-04-26 | — | — | US | disclosed |
| JP-S59144752-A | BENZYLTHIOLCARBAMATE DERIVATIVE, ITS PREPARATION AND HERBICIDE CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT | SUMITOMO CHEM CO LTD | 1984-08-18 | — | — | JP | disclosed |
| JP-S59122459-A | BENZAMIDINE COMPOUND AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE | UBE IND LTD | 1984-07-14 | — | — | JP | disclosed |
| US-4097457-A | Process for preparing high molecular weight polycarbonates | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JA) | 1978-06-27 | — | — | US | disclosed |
| US-4040812-A | Herbicidal carbonates and thiocarbonates of thiadiazolyl-2(1H)-pyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11845726-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | HTR4, SLC6A4, HTR6 | ALDH1A1 1613/4885CA12 2326/4885CA1 2401/4885 |
| US-11945778-B2 | C4-carbonothioate-substituted tryptamine derivatives and methods of using | HTR4, SLC6A4, HTR6 | ALDH1A1 1613/4885CA12 2326/4885CA1 2401/4885 |
| US-20150359786-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF USE THEREOF | TYMP, MAVS, ZC3HAV1 | ALDH1A1 2506/4885CA12 4728/4885CA1 4655/4885 |
| US-20250205197-A1 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | SLC6A4, HTR2B, SLC6A3 | ALDH1A1 1171/4885CA12 699/4885CA1 542/4885 |
| US-20250352513-A2 | SALTS OF C4-CARBOXYLIC ACID- AND C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | SLC6A4, HTR4, SLC6A3 | ALDH1A1 1131/4885CA12 723/4885CA1 567/4885 |
| US-20250206701-A1 | C4-CARBONOTHIOATE-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | HTR4, SLC6A4, HTR6 | ALDH1A1 1613/4885CA12 2326/4885CA1 2401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.